Zdrowie i gospodarka · 21/10/1998

FDA Releases Guidance on Handling Blood Donors with Hepatitis C Virus Antibody

The Food and Drug Administration (FDA) has made available a guidance document outlining procedures for handling blood donors who test repeatedly reactive for antibody to hepatitis C virus (HCV), including quarantine and notification of consignees and recipients of blood and blood components at increased risk for transmitting HCV.